One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
-
Published:2023-11
Issue:
Volume:Volume 17
Page:3601-3611
-
ISSN:1177-5483
-
Container-title:Clinical Ophthalmology
-
language:en
-
Short-container-title:OPTH
Author:
Coney JosephORCID,
McCoy Jasmyne,
Buxy Sinha Samriddhi,
Sonbolian Nina,
Zhou Lujia,
Hull Thomas,
Lewis Shawn,
Miller David,
Novak Michael,
Pendergast Scott,
Pham Hang,
Platt Sean,
Rao Llewelyn,
Schartman Jerome,
Singerman Lawrence,
Donkor RichardORCID,
Fink Margaret,
Zubricky Ryan,
Karcher HeleneORCID
Publisher
Informa UK Limited